New immune-boosting transplant aims to stop leukemia relapse
Disease control
Not yet recruiting
This study tests a stem cell transplant from a matched sibling donor combined with special immune cells (regulatory and conventional T cells) for people with high-risk acute myeloid leukemia (AML). The goal is to prevent the cancer from coming back after the transplant. About 28 …
Phase: PHASE2 • Sponsor: Antonio Pierini • Aim: Disease control
Last updated May 17, 2026 05:08 UTC